J9019 – Injection, asparaginase (erwinaze), 1,000 iu
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9019
- Long description
- Injection, asparaginase (erwinaze), 1,000 iu
- Short description
- Erwinaze injection
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- Added
- January 1, 2013
- Last change
- January 1, 2026 – No change
- Termination date
- December 31, 2025
Frequently asked questions
What is HCPCS code J9019?
J9019 is a HCPCS Level II code for injection, asparaginase (erwinaze), 1,000 iu. It was discontinued on December 31, 2025.
Does Medicare cover J9019?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J8705 – Topotecan, oral, 0.25 mg
- J8999 – Prescription drug, oral, chemotherapeutic, nos
- J9000 – Injection, doxorubicin hydrochloride, 10 mg
- J9003 – Leuprolide injectable (camcevi etm), 1 mg
- J9010 – Injection, alemtuzumab, 10 mg
- J9011 – Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 – Injection, aldesleukin, per single use vial
- J9017 – Injection, arsenic trioxide, 1 mg
- J9020 – Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 – Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 – Injection, atezolizumab, 10 mg
- J9023 – Injection, avelumab, 10 mg
- J9024 – Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025 – Injection, azacitidine, 1 mg
- J9026 – Injection, tarlatamab-dlle, 1 mg
- J9027 – Injection, clofarabine, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.